CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
9.48
+0.52 (5.79%)
At close: Oct 6, 2025, 4:00 PM EDT
9.73
+0.25 (2.65%)
After-hours: Oct 6, 2025, 7:59 PM EDT

CNS Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
57732040
Upgrade
Market Cap Growth
5.89%4.40%109.26%-83.83%-51.07%-37.41%
Upgrade
Enterprise Value
-7-06-41139
Upgrade
Last Close Price
8.9672.2438100.0472000.07632166.321602016.02
Upgrade
PB Ratio
0.341.12-1.500.393.182.87
Upgrade
P/TBV Ratio
0.401.12-0.393.182.87
Upgrade
Debt / Equity Ratio
0.010.05-0.070.050.060.03
Upgrade
Quick Ratio
8.772.910.092.041.937.37
Upgrade
Current Ratio
10.223.430.262.552.888.13
Upgrade
Return on Equity (ROE)
-350.08%-1703.39%-1018.78%-213.68%-144.15%-87.78%
Upgrade
Return on Assets (ROA)
-114.68%-179.08%-159.83%-87.50%-73.58%-49.73%
Upgrade
Return on Capital (ROIC)
-214.51%-785.51%-534.54%-126.44%-86.48%-53.75%
Upgrade
Earnings Yield
-291.17%-214.67%-284.36%-482.14%-73.97%-23.61%
Upgrade
FCF Yield
-392.91%-247.31%-213.35%-333.40%-69.11%-18.32%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q